Cardiosense, a healthcare technology company focused on heart failure care, today announced that the U.S. Food & Drug Administration (FDA) has granted De Novo classification for its PCWP Analysis ...

BOSTON--(BUSINESS WIRE)--Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose ...

Artificial intelligence technologies are advancing the ability to conduct proactive screening to catch the warning signs of serious health conditions, like heart disease. With earlier detection of ...

For World Heart Day 2025, observed annually on Sept. 29 to raise public awareness of cardiovascular diseases and their prevention, Healthcare IT News has been tracking new technologies – and new ...

WHIPPANY, N.J.--(BUSINESS WIRE)--The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone 1, were ...

Bunkerhill Health Secures CMS Reimbursement Pathway for AI Cardiovascular Analysis, Receives FDA Clearance for the First AI Algorithms to Evaluate Coronary and Aortic Valve Calcium on ...

When researchers pooled data from six major semaglutide weight-loss trials and zeroed in on participants aged 65 and older, ...